88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion INCHEON, South Korea , Aug. 28, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today announced a rights offering to raise an expected aggregate amount of KRW 3 trillion to fund investments in ... 2026-08-28T Biotechnology Chemical Health Care/Hospital Medical/Pharmaceuticals
Kazia Therapeutics Limited Announces Proposed Public Offering SYDNEY , Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies ... 2026-08-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kazia Therapeutics Reports 100% Clinical Benefit Rate in Initial Six Patients Treated for Advanced Triple-Negative Breast Cancer Durable Complete Metabolic Response Ongoing Since November 2025 ... 2026-08-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care MELBOURNE, Australia , Aug. 28, 2026 /PRNewswire/ -- Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer ... 2026-08-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum CS2009 Achieved Key Clinical Validations for Efficacy and Safety ... 2026-08-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Appoints Mr. Youchen Chen and Dr. Ian Y. Liu as Executive Directors CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , Aug. 27, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery ... 2026-08-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Reports 2026 Interim Results: Three Integrated Growth Engines Accelerate Execution of Its Platform-Based Strategy CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , Aug. 27, 2026 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed ... 2026-08-27T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS Now spanning ZEISS Retina and Cataract Workflows, the EVA NEXUS ™ ophthalmic surgical system from ZEISS comes in a cataract-only configuration, bringing a tailored approach to different surgical ... 2026-08-27T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Neurophet Supplies 'Neurophet AQUA' and 'Neurophet AQUA AD Plus' to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders Market Provides solutions for analyzing brain atrophy and white matter hyperintensities, as well as monitoring side effects associated with Alzheimer's disease treatments Secures a key reference site at a ... 2026-08-27T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion Highlights: ... 2026-08-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved